BiotechTube
Home/Cell Source/Prof. Yair Reisner, Ph.D.
PY

Prof. Yair Reisner, Ph.D.

Scientific Advisory Board Chair

Cell Source

Therapeutic Areas

OncologyHematologyTransplantationAutoimmune

Cell Source Pipeline

DrugIndicationPhase
Veto Cell‑augmented Allogeneic HSCTHematologic malignancies and non‑malignant disordersPhase 1/2
Veto Cell CAR‑T for LeukemiaAcute Lymphoblastic LeukemiaPreclinical
Veto Cell CAR‑T for LymphomaDiffuse Large B‑Cell LymphomaPreclinical
Veto Cell Therapy for Type‑1 DiabetesAutoimmune DiabetesPreclinical

Leadership Team at Cell Source

DZ
Dr. Zelig Eshhar
Scientific Advisor
View full Cell Source profile